THRB and endometrial cancer: The previously unreported observation that THRB is lost in a subset of endometrial cancers and is associated with better 5-year survival could aid in the development of prognostic biomarkers and of targeted therapeutic regimens for endometrial carcinoma that modulate thyroid receptor signaling.